arrow_back Back to App

New Mifepristone Rules: Warning Labels and Support Hotline.

This new law requires a warning label on mifepristone packaging about the possibility of counteracting its effects. Additionally, a 24/7 hotline will be established to provide information and referrals to facilities offering services to reverse the drug's effects. The aim is to ensure women have access to information about alternative options.
Key points
Mandatory warning label on mifepristone stating its effects can be counteracted by natural progesterone.
Establishment of a 24/7 toll-free hotline for women seeking to reverse the effects of mifepristone.
The hotline will only refer to healthcare providers offering abortion pill reversal services.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_796
Sponsor: Rep. Miller, Mary E. [R-IL-15]
Process start date: 2025-01-28
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Second Chance for Moms Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_796.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-01-28.

What are the main provisions?

Key points include:

  • Mandatory warning label on mifepristone stating its effects can be counteracted by natural progesterone.
  • Establishment of a 24/7 toll-free hotline for women seeking to reverse the effects of mifepristone.
  • The hotline will only refer to healthcare providers offering abortion pill reversal services.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Miller, Mary E. [R-IL-15].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health